Nasdaq · CIK 0001599298
SMMT Summit Therapeutics Inc.
Insider trading from SEC Form 4. Last filing Jan 14, 2025.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
6
with a Form 4 at this company
Signals
Open-market buys and sells at Summit Therapeutics Inc., scored.
No scored open-market trades yet. Grants, exercises and other rows are below.
Transactions
The last 10 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 12, 2025 | Bhaskar Anand Chief Accounting Officer | AGrant or award Stock Option (right to buy)derivative | +75,000 | - | - | 75,000 | Jan 14, 2025 |
| Jan 2, 2025 | Robert F. Booth director | AGrant or award Stock Option (right to buy)derivative | +35,000 | - | - | 35,000 | Jan 6, 2025 |
| Jan 2, 2025 | Alessandra Cesano director | AGrant or award Stock Option (right to buy)derivative | +35,000 | - | - | 35,000 | Jan 6, 2025 |
| Jan 2, 2025 | Kenneth A Clark director | AGrant or award Stock Option (right to buy)derivative | +35,000 | - | - | 35,000 | Jan 6, 2025 |
| Jan 2, 2025 | Jeff Huber director | AGrant or award Stock Option (right to buy)derivative | +35,000 | - | - | 35,000 | Jan 6, 2025 |
| Jan 2, 2025 | Robert F. Booth director | AGrant or award Stock Option (right to buy)derivative | +6,855 | $9.18 | $63k | 6,855 | Jan 6, 2025 |
| Jan 2, 2025 | Alessandra Cesano director | AGrant or award Stock Option (right to buy)derivative | +3,073 | $9.18 | $28k | 3,073 | Jan 6, 2025 |
| Jan 2, 2025 | Kenneth A Clark director | AGrant or award Stock Option (right to buy)derivative | +16,991 | $9.18 | $156k | 16,991 | Jan 6, 2025 |
| Jan 2, 2025 | Robert W Duggan Co-Chief Executive Officer | AGrant or award Stock Option (right to buy)derivative | +10,724 | $9.18 | $98k | 10,724 | Jan 6, 2025 |
| Oct 11, 2024 | Kenneth A Clark director | AGrant or award Stock Option (right to buy)derivative | +200,000 | - | - | 200,000 | Oct 15, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Bhaskar AnandChief Accounting Officer
- Robert F. Boothdirector
- Alessandra Cesanodirector
- Kenneth A Clarkdirector
- Robert W DugganCo-Chief Executive Officer
- Jeff Huberdirector
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.